methyldopa has been researched along with bendroflumethiazide in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (76.19) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Spira, M | 1 |
| Dollery, CT; Hamilton, CA; Jones, DH; Polak, G; Reid, JL | 1 |
| Blake, S; MacDonald, D | 1 |
| Conway, J | 1 |
| Perrier, CV; Sitavanc, L | 1 |
| Baker, P; Chadd, MA; Humphreys, DM; Leather, HM | 1 |
| Arrowsmith, DE; Dormandy, TL; Heal, J; Hoffbrand, BI; Libman, LJ | 1 |
| Baker, PA; Chadd, MA; Humphreys, DM; Leather, HM | 1 |
| Wilkinson, DM | 1 |
| Lindner, O; Pasz, T; Schubert, R | 1 |
| Ellis, R; Wood, SJ | 1 |
| Wheatley, D | 1 |
| Latham, L; Lorimer, AR; McAreavey, D; McLaren, AD; Ramsey, LE; Reid, JL; Robertson, JI; Robertson, MP; Weir, RJ | 1 |
| Brøns, M; Christensen, CK; Geday, E; Jacobsen, FK; Jensen, SN; Kristensen, BO; Linde, NC | 1 |
| Dollery, CT; Orozco-Gonzalez, M; Polak, G; Wright, JM | 1 |
| Gueyffier, F; Musini, VM; Puil, L; Salzwedel, DM; Wright, JM | 1 |
3 review(s) available for methyldopa and bendroflumethiazide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Current antihypertensive drugs: mechanism of action].
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Catecholamines; Central Nervous System; Clonidine; Diazoxide; Diuretics; Drug Synergism; Guanethidine; Guanidines; Humans; Hydralazine; Methyldopa; Propranolol; Reserpine; Spironolactone | 1973 |
Pharmacotherapy for hypertension in adults aged 18 to 59 years.
Topics: Adult; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Cause of Death; Coronary Disease; Humans; Hypertension; Methyldopa; Middle Aged; Myocardial Infarction; Patient Dropouts; Propranolol; Randomized Controlled Trials as Topic; Stroke; Young Adult | 2017 |
11 trial(s) available for methyldopa and bendroflumethiazide
| Article | Year |
|---|---|
A crossover comparison of a timolol/bendrofluazide combination and methyldopa in essential hypertension.
Topics: Adult; Aged; Bendroflumethiazide; Blood Pressure; Drug Combinations; Female; Heart Rate; Humans; Hypertension; Male; Methyldopa; Middle Aged; Timolol | 1977 |
The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment.
Topics: Adult; Atenolol; Bendroflumethiazide; Birth Weight; Drug Therapy, Combination; Embryonic and Fetal Development; Female; Fetal Death; Humans; Hypertension; Infant, Newborn; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria | 1991 |
Third-line therapy. A cautionary note.
Topics: Atenolol; Bendroflumethiazide; Captopril; Chlorthalidone; Female; Humans; Hypertension; Male; Methyldopa; Nifedipine | 1985 |
A controlled trial of hypotensive agents in hypertension in pregnancy.
Topics: Abortion, Spontaneous; Antihypertensive Agents; Bendroflumethiazide; Birth Weight; Creatinine; Female; Humans; Infant Mortality; Infant, Newborn; Kidney Function Tests; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Prognosis; Proteinuria; Time Factors | 1968 |
Control of moderately raised blood pressure. Report of a co-operative randomized controlled trial.
Topics: Aged; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Debrisoquin; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Placebos; Potassium; Prospective Studies | 1973 |
Controlled trial of hypotensive agents in hypertension in pregnancy.
Topics: Bendroflumethiazide; Birth Weight; Clinical Trials as Topic; Female; Fetal Death; Humans; Hypertension; Kidney Function Tests; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular | 1968 |
[Comparative assessment of the results of new antihypertensive drugs].
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Bendroflumethiazide; Female; Humans; Hypertension; Hypertension, Renal; Male; Methyldopa; Middle Aged | 1968 |
Psychological stress and cardiovascular diseases.
Topics: Anti-Anxiety Agents; Bendroflumethiazide; Cardiovascular Diseases; Clinical Trials as Topic; Clorazepate Dipotassium; Humans; Hypertension; Medazepam; Methyldopa; Propranolol; Stress, Psychological | 1984 |
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Methyldopa; Middle Aged; Minoxidil; Prazosin | 1984 |
Antihypertensive effect of atenolol (100 mg once a day) and methyldopa (250 mg thrice a day). A double-blind cross-over multicentre study.
Topics: Adult; Aged; Atenolol; Bendroflumethiazide; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Male; Methyldopa; Middle Aged; Propanolamines | 1981 |
Duration of effect of single daily dose methyldopa therapy.
Topics: Adult; Bendroflumethiazide; Blood Pressure; Double-Blind Method; Drug Administration Schedule; Heart Rate; Humans; Hypertension; Methyldopa; Middle Aged; Physical Exertion; Time Factors | 1982 |
7 other study(ies) available for methyldopa and bendroflumethiazide
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Sympathetic nervous function and renin activity in hypertensives on long term drug treatment with propranolol, methyldopa or bendrofluazide.
Topics: Adult; Antihypertensive Agents; Bendroflumethiazide; Blood Pressure; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Propranolol; Renin; Sympathetic Nervous System | 1978 |
Blood lipids and the treatment of essential hypertension with methyldopa and bendrolfuazide.
Topics: Adult; Aged; Bendroflumethiazide; Drug Therapy, Combination; Female; Humans; Hypertension; Lipids; Male; Methyldopa; Middle Aged | 1974 |
Hypertension. I.
Topics: Adult; Bendroflumethiazide; Cerebrovascular Disorders; Coronary Disease; Diuretics; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Obesity; Pyelonephritis | 1971 |
Gynecomastia in renal failure.
Topics: Aged; Bendroflumethiazide; Furosemide; Gynecomastia; Humans; Kidney Failure, Chronic; Male; Methyldopa | 1968 |
The use of timolol/bendrofluazide (Prestim) in the treatment of hypertensive patients failing to respond to other antihypertensives.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Bendroflumethiazide; Diuretics; Drug Combinations; Female; Humans; Hypertension; Male; Methyldopa; Middle Aged; Timolol | 1983 |